Herpes is an incurable virus that spreads via physical contact in the mouth or genitals. However, medication can limit ...

HealthDay News — A once-promising investigational vaccine against herpes viruses showed only 20% efficacy against herpes genital disease in a large clinical trial designed to mimic the general ...

The HSV testing market sees growth opportunities in advanced molecular assays, increased adoption in decentralized settings, ...

Late-breaking oral presentation highlights interim Phase 1b data reported earlier this year for two cohorts in participants with recurrent ...

This is a preview. Log in through your library . Abstract Objective: The objective of this study was to estimate the prevalence and correlates of herpes simplex virus type 2 infection in women in an ...

Assembly Biosciences Inc. has selected development candidate ABI-5366 to progress to IND-enabling studies from its long-acting herpes simplex virus type 2 (HSV-2) helicase inhibitor program for ...

This is a preview. Log in through your library . Abstract Background and Objectives: The genital herpes epidemic continues, in part, because patients with subclinical or atypical presentations cannot ...

Assembly Biosciences (ASMB) announced that interim Phase 1b clinical data for its long-acting herpes simplex virus helicase-primase inhibitor ...

Assembly Biosciences, Inc., a biotechnology company developing innovative therapeutics targeting serious viral diseases, announced positive interim antiviral activity, clinical outcomes, safety and ...